Clin2
NCT07311330Possibly a fitRecruiting

Investigation of YN001 for Men with ED and Artery Disease

Atherosclerotic Cardiovascular Disease (ASCVD)Erectile Dysfunction

Part of Heart & circulation, Kidney & urinary, Mental health clinical trials.

This study tests an investigational drug (YN001) for men with mild to moderate erectile dysfunction who also have hardening of the arteries (atherosclerosis) in the heart, brain, or legs. The goal is to see if the drug helps improve erections while being safe.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
40 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You have had mild to moderate erectile dysfunction for at least 3 months, and a score of 21 or less on the IIEF-5 questionnaire.
  • You have a history of heart or blood vessel problems such as coronary artery disease, stroke, or clogged arteries in the neck, arms, or legs.
  • You are willing to not father a child or donate sperm during the study and for 3 months after, and to use effective birth control.
  • You have not had a stroke in the last 6 months.
  • You do not have other conditions that could cause erectile dysfunction (like uncontrolled diabetes, hormone problems, or severe liver or kidney disease).
  • You have not used certain erectile dysfunction treatments (like injections or vacuum devices) that you cannot stop during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07356609Not yet recruiting
Sildenafil for erectile dysfunction in men with diabetes

This study is for men with diabetes and erectile dysfunction (trouble getting or keeping an erection). It tests the safety and effectiveness of sildenafil (Viagra) in this group. You will be prescribed sildenafil and your results will be tracked to see how well it works and if it is safe.

NCT07177326Not yet recruiting· Phase 3
Comparing two drug combinations for erectile dysfunction

This study tests two different ways to treat erectile dysfunction (ED): a combination of two commonly used medications (tadalafil and sildenafil) versus a single medication (tadalafil). It aims to see which approach works better and is safe for men with ED.

NCT07231185Not yet recruiting· Phase 2
Sildenafil for erectile dysfunction in adult men

This study tests a new form of sildenafil (the active ingredient in Viagra) for treating erectile dysfunction in men. It aims to see how well it works and how safe it is, and you'll need to track your progress using a smartphone app.

NCT07117383Not yet recruiting· Phase 1
Comparing sildenafil options in healthy men

This study compares three forms of sildenafil — a common erectile dysfunction medication — to see how well the body absorbs them after a high-fat meal. It is an early-stage trial in healthy men to check for safety and how the drugs work.

New York, New York
NCT05451563Recruiting
Wearable device trial for erectile dysfunction

This trial studies a wearable device designed to help men with erectile dysfunction (trouble getting or keeping an erection). You may be able to take part if you have a willing female partner and you can safely try the device during the study.

Stanford, California
NCT06720597Recruiting
Testing a device for blood vessel health in erectile dysfunction

This study tests a device called EndoPAT to check how well the blood vessels in your penis are working. It may help doctors better understand erectile dysfunction or low testosterone.

Newport Beach, California

Hear when a new Atherosclerotic Cardiovascular Disease (ASCVD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.